🇺🇸 FDA

Intelligence · Clinical Pipeline

Regeneron UK Pipeline

All ClinicalTrials.gov programs at Regeneron UK — phase, modality, and trial IDs.

Programs
493

Quick answer

Regeneron UK has 493 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. REGN4336

    Regeneron UK Limited

    Metastatic Castration-resistant Prostate Cancer

    phase 2 small molecule active

    1 trial

  2. REGN4461

    Regeneron UK Limited

    Familial Partial Lipodystrophy

    phase 2 small molecule terminated

    1 trial

  3. REGN475

    Regeneron UK Limited

    Osteoarthritis of the Knee

    phase 2 small molecule completed

    1 trial

  4. REGN475

    Regeneron UK Limited

    Osteoarthritis

    phase 2 mab terminated

    1 trial

  5. REGN475

    Regeneron UK Limited

    Sciatica

    phase 2 small molecule completed

    1 trial

  6. REGN475/SAR164877

    Regeneron UK Limited

    Back Pain

    phase 2 small molecule terminated

    1 trial

  7. REGN475/SAR164877

    Regeneron UK Limited

    Abdominal Pain Upper

    phase 2 small molecule terminated

    1 trial

  8. REGN5069

    Regeneron UK Limited

    Osteoarthritis of the Knee

    phase 2 small molecule terminated

    1 trial

  9. REGN5093

    Regeneron UK Limited

    NSCLC

    phase 2 small molecule active

    1 trial

  10. REGN5381

    Regeneron UK Limited

    Uncontrolled Hypertension

    phase 2 small molecule terminated

    1 trial

  11. REGN5381

    Regeneron UK Limited

    Heart Failure

    phase 2 small molecule terminated

    2 trials

  12. REGN5459

    Regeneron UK Limited

    Relapsed Multiple Myeloma

    phase 2 small molecule completed

    1 trial

  13. REGN5668

    Regeneron UK Limited

    Ovarian Cancer

    phase 2 small molecule active

    1 trial

  14. REGN5678

    Regeneron UK Limited

    Metastatic Castration-Resistant Prostate Cancer (mCRPC)

    phase 2 small molecule active

    1 trial

  15. REGN7041

    Regeneron UK Limited

    Active Noninfectious Uveitis Affecting the Posterior Segment

    phase 2 small molecule active

    1 trial

  16. REGN7075

    Regeneron UK Limited

    Advanced Solid Tumors

    phase 2 small molecule active

    1 trial

  17. REGN7508

    Regeneron UK Limited

    Venous Thromboembolism

    phase 2 small molecule completed

    1 trial

  18. REGN7544

    Regeneron UK Limited

    Postural Orthostatic Tachycardia Syndrome (POTS)

    phase 2 small molecule active

    1 trial

  19. REGN7544

    Regeneron UK Limited

    Sepsis-Induced Hypotension

    phase 2 small molecule completed

    1 trial

  20. REGN7999

    Regeneron UK Limited

    Non-Transfusion Dependent Beta-Thalassemia (NTDT)

    phase 2 small molecule active

    1 trial

  21. REGN846

    Regeneron UK Limited

    Pruritus

    phase 2 small molecule terminated

    1 trial

  22. REGN910-3

    Regeneron UK Limited

    Neovascular Age-Related Macular Degeneration

    phase 2 small molecule completed

    2 trials

  23. REGN910-3

    Regeneron UK Limited

    Diabetic Macular Edema

    phase 2 small molecule completed

    1 trial

  24. REGN9933

    Regeneron UK Limited

    Venous Thromboembolism

    phase 2 small molecule completed

    2 trials

  25. REGV131

    Regeneron UK Limited

    Hemophilia B

    phase 2 small molecule active

    1 trial

  26. Rilonacept

    Regeneron UK Limited

    Cold Contact Urticaria

    phase 2 small molecule completed

    1 trial

  27. Rilonacept

    Regeneron UK Limited

    Chronic Kidney Disease

    phase 2 small molecule terminated

    1 trial

  28. Rilonacept

    Regeneron UK Limited

    Scleroderma

    phase 2 small molecule completed

    1 trial

  29. S095018

    Regeneron UK Limited

    Non-small Cell Lung Cancer (NSCLC)

    phase 2 small molecule active

    1 trial

  30. SAR440340

    Regeneron UK Limited

    Asthma

    phase 2 small molecule completed

    1 trial

  31. SAR440340

    Regeneron UK Limited

    Chronic Obstructive Pulmonary Disease

    phase 2 small molecule completed

    1 trial

  32. SAR444881

    Regeneron UK Limited

    Solid Tumors

    phase 2 small molecule active

    1 trial

  33. SDREGN2810

    Regeneron UK Limited

    Advanced Non-Small Cell Lung Carcinoma

    phase 2 small molecule terminated

    1 trial

  34. SNS-101 (anti-VISTA)

    Regeneron UK Limited

    Solid Tumor, Adult

    phase 2 small molecule active

    1 trial

  35. Sarilumab

    Regeneron UK Limited

    Juvenile Idiopathic Arthritis

    phase 2 small molecule completed

    1 trial

  36. Sarilumab

    Regeneron UK Limited

    Morphea, Plaque Form

    phase 2 small molecule terminated

    1 trial

  37. Sarilumab

    Regeneron UK Limited

    Ankylosing Spondylitis

    phase 2 small molecule terminated

    2 trials

  38. Sarilumab SAR153191 (REGN88)

    Regeneron UK Limited

    Juvenile Idiopathic Arthritis

    phase 2 small molecule active

    1 trial

  39. Sub-tenon injection of saline followed by a sub-tenon injection of aflibercept

    Regeneron UK Limited

    Thyroid Eye Disease

    phase 2 small molecule completed

    1 trial

  40. Tirzepatide

    Regeneron UK Limited

    Obesity

    phase 2 small molecule completed

    1 trial

  41. Trevogrumab-Part A

    Regeneron UK Limited

    Obesity

    phase 2 small molecule active

    1 trial

  42. Ubamatamab

    Regeneron UK Limited

    Recurrent Ovarian Cancer

    phase 2 small molecule active

    1 trial

  43. Ubamatamab

    Regeneron UK Limited

    Ovarian Cancer

    phase 2 small molecule active

    1 trial

  44. Ubamatamab

    Regeneron UK Limited

    Advanced/Metastatic Non-Small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  45. Ubamatamab

    Regeneron UK Limited

    SMARCB1-Deficient Malignancies

    phase 2 small molecule active

    1 trial

  46. VEGF Trap Eye

    Regeneron UK Limited

    Macular Degeneration

    phase 2 small molecule completed

    1 trial

  47. VV1

    Regeneron UK Limited

    Melanoma

    phase 2 mab active

    1 trial

  48. Vonsetamig

    Regeneron UK Limited

    Chronic Kidney Disease (CKD)

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many pipeline programs does Regeneron UK have?

493 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.